TIPE2 suppresses TLR4-mediated development of colon cancer by inhibiting caspase-8 activity [14], while its expression is positively correlated with TNM staging in renal cell carcinoma (RCC) patients [15]. The gene discussed is TIPE2; the disease is renal cell carcinoma.